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Abstract Axillary plexus blocks (AXB) are widely used
for upper limb operations. It is recommend that AXB
should be performed using a multiple injection technique.
Information about the course and position of the muscu-
locutaneous nerve (MCN) is of relevance for AXB per-
formance. The objective of this study was to examine the
position of the MCN and its relationship to the axillary
sheath using MRI. 54 patients underwent an AXB with
40 ml of local anaesthetic before MRI examination. The
course of the MCN and the position where it left the
axillary sheath and perforated the coracobrachial muscle
(MCN exit point), in relation to the axillary artery and the
block needle insertion point in the axillary fold, were
recorded. The MCN was seen clearly in 23, partly in 26,
and not identified in five patients at the MCN exit point.
The mean distance from the insertion point of the block
needle in the axillary fold to the MCN exit point was
36.8 mm (SD = 18.9, range: 0–90.5). In 37 patients the
MCN exit point was positioned inside the Q1 quadrant
(lateral anterior to the axillary artery) and in 11 patients
inside the Q2 quadrant (medial anterior to the axillary
artery). There is a wide variability as to where the
musculocutaneous nerve (MCN) leaves the axillary sheath.
Therefore multiple injection techniques, or the use of a
proximally directed catheter, should be appropriate to
block the MCN.
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1 Introduction
Axillary plexus blocks (AXB) are widely used as an
anaesthetic method for upper limb operations. It is rec-
ommend that AXB should be performed using a multiple
injection technique [1]. At terminal nerve level, the mus-
culocutaneous nerve (MCN) is usually positioned outside
the axillary sheath. There is an ongoing discussion as to
whether a selective block of the MCN is necessary to
achieve a successful AXB [2, 3]. The objective in this
study was to examine the position of the MCN and its
relationship to the axillary sheath using MRI. Information
about the course of the MCN can indicate how, and where,
the MCN can be blocked when performing AXB.
2 Methods
Ethical approval for this study (Ethical Committee No
S-04115) was provided by the Committee for Medical
Research Ethics, Region South East (REK Sør-Øst), Pb
1130 Blindern, 0318 Oslo, Norway on June 8th, 2004 as for
a previous study [4].
The study was conducted at Oslo University Hospital,
Rikshospitalet, in the period November 10th, 2014–Fe-
bruary 1st, 2015. Forty five patients from a study on
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axillary brachial plexus blocks [5] and nine patients from a
pilot study [4] were analysed as one group using the
existing MRI data.
All patients underwent an AXB with 40 ml of local
anaesthetic (LA) injected before MRI scanning (Achieva
3T, Philips Healthcare, The Netherlands) was performed
[4, 5]. MRI scanning was performed immediately after
completion of the block-procedures.
The patients were examined in the horizontal supine
position with the arms adducted. T1- and T2-weighted
images were obtained according with a previously descri-
bed protocol [4], and the images underwent a consensus
assessment by the three authors.
The course of the MCN and the surrounding anatomy
was analysed in the short axis view (cross-sectional, Fig. 1)
and in the long axis view (coronal, Fig. 2). The MCN exit
point was defined as the position where the nerve left the
neurovascular bundle into the coracobrachial muscle
(Fig. 1).
The MCN exit point was measured with reference to the
top of the humeral head (Fig. 2). Similarly, the most cra-
nial part of the axillary fold was defined as the block needle
insertion point, and the distance from this point to the top
of the humeral head was recorded (Fig. 2). The difference
between these two measurements gave the distance from
the block needle insertion point to the MCN exit point.
The visibility assessment was performed at the MCN
exit point and was scored as 0 = not visible, 1 = partly
visible and 2 = clear visible.
The positions of the MCN exit points were plotted
graphically. The estimated diameters were 8 mm for the
artery and 3 mm for the nerves (Figs. 3 and 4).
The MCN exit point was also described by the four
quadrant positions: Q1 = the lateral anterior, Q2 = the
medial anterior, Q3 = the medial posterior and Q4 = the
lateral posterior quadrant (Fig. 4). The angel and distance
from the mid axis of the axillary artery to the MCN exit
point was recorded, and a lateral horizontal line towards
the humerus was defined as the zero angel line (Fig. 1).
2.1 Statistics
For statistical analysis, we used SPSS version 22 (IBM
Corporation, Armonk, New York, USA). Data were
described by mean, standard deviation (SD), range and
counts.
3 Results
Of the 54 patients, 30 had a plexus block on the right and
24 on the left side. In 23 patients the MCN exit point was
clearly and 26 patients partly visible. In 5 patients the
MCN exit point could not be identified.
The mean distance from the top of the humeral head to
the insertion point of the block needle was 98.4 mm
(SD = 10.9, range: 81.4–132). The MCN exit point was
positioned at a mean distance of 61.5 mm (SD = 17.6,
range: 29.6–106.7) from the humeral head. Thus, the mean
distance from the insertion point of the block needle in the
axillary fold to the MCN exit point was 36.8 mm
(SD = 18.9, range: 0–90.5; Fig. 3).
The mean angel from the lateral horizontal line to the
MCN exit point was 69.48 (SD = 39.7, range: -8.1 to
160.2) for all patients (Fig. 4). In 37 patients the MCN
exit point was positioned inside the Q1 quadrant (lateral
anterior to the axillary artery) and in 11 patients inside the
Q2 quadrant (medial anterior to the axillary artery). In only
one patient the MCN exit point was found in the Q4
quadrant at -8.1 to the zero angel line (Fig. 4). The
Fig. 1 MRI of the right axilla,
cross-sectional view. T2-
weighted image with fat
suppression from a patient with
a successful sensory block after
a single local anaesthetic (LA)
injection. The LA appears
white. The musculocutaneous
nerve (MCN) is clearly seen
before entering the
coracobrachial muscle. The
lateral horizontal line (red)
towards the humerus head was
defined as the zero angel line
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average distance from the centre of the artery to the MCN
exit point was 10.8 mm (SD = 3.0, range: 4.9–17.5).
4 Discussion
The MRI of the axillary brachial plexus from 54 patients
showed a wide variability as to where the musculocuta-
neous nerve (MCN) leaves the axillary sheath. The MCN
exit points were mainly localized in the lateral anterior (Q1)
and the medial anterior (Q2) quadrant and spread over a
distance of approximately 10 cm proximally to the axillary
fold.
The large distance between the MCN exit point and the
insertion point of the block needle in the axillary fold,
which we found in our study, can explain the incomplete
success rates in some axillary blocks techniques when the
MCN is not selectively blocked. Block success rates of the
MCN can range from 27 to 40 % as seen in a study without
a selective block of the nerve [6]. With a selective block on
the other hand, success rates for MCN blocks above 90 %
are achieved [6–8].
According to the concept of a continuous neurovascular
sheath, a sufficiently high injection volume should give an
adequate proximal spread to the MCN [9]. However, sev-
eral studies have demonstrated that the brachial plexus
Fig. 2 MRI of right shoulder,
coronal view, in one of the
patients. T1-weighted image.
With a reference point at the top
of the humeral head, the
distances (blue line, green line)
to the MCN exit point (N) and
the insertion point of the block
needle (I) were measured. The
humeral shaft (red line) served
as reference line
5 cm 10 cm
axillary artery
Fig. 3 The exit points of the musculocutaneous nerve into the
coracobrachial muscle in relation to the insertion point of the block
needle (arrow) in the axillary fold, and in relation to the centre of the
artery
lateral
0°
anterior
90°
medial
180°
posterior
270°
Fig. 4 The exit points of the musculocutaneous nerve into the
coracobrachial muscle in relation to the quadrants and the axillary
artery (centre). The four quadrants: Q1 = the lateral anterior (0–
90), Q2 = the medial anterior (90–180), Q3 = the medial posterior
(180–270) and Q4 = the lateral posterior (270–360) quadrant
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sheath is divided by connective tissue septa into multiple
compartments [10, 11]. LA spread, especially in the cross-
sectional plane, can be inhibited. The wide spread of the
MCN exit points in the two anterior quadrants favour a
multiple injection technique, or a selective block, in order
to achieve a successful AXB.
In our previous study, block success of the MCN was
100 % when an LA volume of 40 ml was applied with
multiple injections through a proximal catheter combined
with two deposits lateral and medial to the axillary artery
(without blocking the MCN selectively). When only a
proximal catheter was used for LA injection, the success
rate for MCN block decreased to 73 % [5].
Non-ultrasound-guided and single injection axillary
plexus block techniques have typically used high doses of
LA [12–14]. We therefore considered the 40 ml LA vol-
ume used in our study as adequate in order to fill up the
axillary sheath [15]. When nerves are detected individually
by ultrasound guidance or electrical nerve stimulations,
lower LA volumes are appropriate [12, 16, 17].
Our study has several limitations. MRI measurements
are substantially observer dependant. Therefore the images
were discussed among the three authors, and a consensus
agreement was achieved. In five of the 54 patients (9 %)
the MCN exit point could not be identified. One reason for
our missing data may be that the MCN exit point was
outside the scanning field. However, the MCN can some-
times be missing, or it demonstrates unusual anatomy with
an alternative course, passing over the surface of the
coracobrachial muscle instead of perforating it [18–20]. In
the study of Guerri-Guttenberg et al. [19] the MCN was
absent at a frequency of 3.6 %, and in 11 % of the dis-
sections the nerve did not perforate the coracobrachial
muscle.
The MRI examination was performed just after the LA
had been injected. The distortion of the anatomy [4], due to
the injection, may have altered the MRI measurements.
Especially the distance between the MCN exit point and
the artery could be increased.
Because of the closed scanner construction, our MRI
examinations were performed with the arm adducted.
Distances and nerve positions might differ when the arm is
abducted, as in the typical position when performing the
AXB.
5 Conclusion
There is a wide variability as to where the musculocuta-
neous nerve (MCN) leaves the axillary sheath. Therefore
multiple injection techniques, or the use of a proximally
directed catheter, should be appropriate to block the MCN.
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